Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ricorich-DHA is a multi-ingredient nutritional supplement developed and marketed by Oscorp Remedies. It is formulated as a softgel capsule containing a combination of the carotenoid antioxidant lycopene, omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid), vitamins (C and E), and essential minerals (Zinc and Selenium). The supplement is designed to provide antioxidant support, promote cardiovascular health, and support cognitive function. Lycopene acts as a potent scavenger of reactive oxygen species, while DHA and EPA serve as essential structural components of cell membranes and modulate inflammatory pathways through PPAR activation. It is primarily used to address nutritional gaps and support overall metabolic and cellular health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ricorich-DHA.